Study Conduct

Perlara partners with third patient advocacy group

Tuesday, January 31, 2017

Perlara, a global patient portal and drug discovery platform company for the one in 10 families affected by rare disease, has announced the formation of a PerlQuest partnership with Michigan-based Maggie’s PMM2-CDG Cure. PMM2-CDG, formerly known as congenital disorder of glycosylation type 1a, is caused by mutations in the evolutionarily conserved gene PMM2. There are currently no FDA approved treatments for PMM2-CDG.

[Read More]

Align Biopharma launched as industry standards group

Monday, January 30, 2017

Six of the top 25 largest global pharmaceutical companies announced the formation of Align Biopharma, a new group dedicated to setting technology standards that will make it faster and easier for healthcare professionals (HCPs) to connect with the life sciences industry. Founding members, with input from across the industry, will develop open standards and solutions for companies to streamline how HCPs get the drug and treatment information they need to deliver improved care to patients.

[Read More]

PhRMA launches media initiative

Tuesday, January 24, 2017

The Pharmaceutical Research and Manufacturers of America (PhRMA) has launched a national, multi-year advertising and public affairs initiative on behalf of America’s biopharmaceutical companies. The campaign, GOBOLDLY, will showcase the industry’s unsung heroes driving cutting-edge advances in science and highlight the tremendous opportunity that exists to tackle our most complex and devastating health conditions. 

[Read More]

FDA, IBM partner on the secure exchange of clinical data

Monday, January 23, 2017

Secure storage and controlled access to sensitive patient data are critical aspects of the clinical trial process. Investigators may need to access huge data sets shared across national and international sites. The amount and sheer number of types of data is rapidly increasing as the use of mobile and wearable devices and the querying of genomic databases are incorporated into trial design.

[Read More]

Three Questions: Mohammad A. Millwala, DM Clinical Research

Monday, January 23, 2017

CWWeekly presents this feature as a spotlight on issues faced by executives in clinical research. This week, writer Karyn Korieth spoke with Mohammad A. Millwala, CEO of DM Clinical Research, a network of investigative sites based out of Tomball, Texas. DM Clinical Research was a finalist for the Society for Clinical Research Sites’ 2016 Site Patient Recruitment Innovation Award (SPRIA), which recognizes research sites that have developed and implemented innovative patient recruitment programs.

[Read More]

DaVita, Prism choose Verified Clinical Trials to prevent duplicate enrollment

Friday, January 20, 2017

DaVita Clinical Research (DCR), a specialty CRO with services spanning the full spectrum of drug and device development, and Prism Clinical Research, a provider of fully integrated clinical research services to pharma/device companies and clinicians, have announced Verified Clinical Trials (VCT) has been selected by both companies as an exclusive provider to further prevent duplicate enrollment in clinical trials.

[Read More]

Interface Clinical Research launches new clinical trials model

Wednesday, January 18, 2017

New clinical trials company Interface Clinical Research outlined a new model for running primary care clinical trials. Interface will work in partnership with GP practices across the U.K. to deliver large numbers of suitable patients for phase III and IV clinical trials. Typically, 48% of sites used in a clinical trial fail to recruit a single patient. Interface believe they have the capability to recruit hundreds of patients per site.

[Read More]

Report: Poor physician/nurse engagement contributes to low patient recruitment rates

Tuesday, January 17, 2017

Although physicians and nurses are familiar with, and comfortable discussing, clinical trials, they refer a mere fraction of their patients for these studies, reflecting, in part, a failure by sponsors, CROs and investigative site personnel to engage health care providers as partners in the clinical research process, according to a recently completed analysis conducted by the Tufts Center for the Study of Drug Development.

[Read More]

Malecare launches trial accrual system Cancergraph

Tuesday, January 17, 2017

Malecare, a U.S. men’s cancer survivor support and advocacy national nonprofit organization, launched Cancergraph, a mobile application that tracks cancer symptoms, disease states and quality of life reports in real time and quickly identified its primary value as a clinical trial accrual system. Cancergraph distills each users’ health data to provide, in real time, only the specific cancer trials that apply to them. 

[Read More]